Anti-NMDAR2B antibody [NR2B]
3
(3 Reviews)
|
(40 Publications)
Mouse Monoclonal NMDAR2B antibody. Suitable for ICC, Flow Cyt, WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 40 publications. Immunogen corresponding to Recombinant Fragment Protein within Rat Grin2b aa 900 to C-terminus.
View Alternative Names
GluN2B, Glutamate [NMDA] receptor subunit epsilon-2, N-methyl D-aspartate receptor subtype 2B, NMDAR2B, NR2B, Grin2b
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NMDAR2B antibody [NR2B] (AB28373)
ab28373 staining NMDAR2B in Human breast tissue sections (right) compared with negative control (left) by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with paraformaldehyde and blocked with 3% H2O2-methanol for 15 minutes at room temperature; antigen retrieval was by heat mediation in a sodium citrate buffer. Samples were incubated with primary antibody (1/20) overnight at 4°C. A HRP-conjugated secondary antibody was used for detection.
- Flow Cyt
Unknown
Flow Cytometry - Anti-NMDAR2B antibody [NR2B] (AB28373)
Overlay histogram showing SH-SY5Y cells stained with ab28373 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab28373, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in SH-SY5Y cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- WB
AbReview27255****
Western blot - Anti-NMDAR2B antibody [NR2B] (AB28373)
Samples were incubated with primary antibody for 12 hours at 4°C.
Blocked with 5% milk for 1 hour at 22°C.
All lanes:
Western blot - Anti-NMDAR2B antibody [NR2B] (ab28373) at 1/500 dilution
All lanes:
Rat P14 Cortex Lysate, vesicular fraction at 5 µg
Secondary
All lanes:
HRP conjugated Donkey anti-mouse IgG at 1/15000 dilution
Predicted band size: 166 kDa
true
This image is courtesy of an anonymous Abreview
- WB
Unknown
Western blot - Anti-NMDAR2B antibody [NR2B] (AB28373)
Lanes 2 - 4:
Western blot - Anti-NMDAR2B antibody [NR2B] (ab28373) at 1/500 dilution
Lanes 5 - 7:
Western blot - Anti-NMDAR2B antibody [NR2B] (ab28373) at 1/1000 dilution
Lanes 3 and 6:
Mouse brain (50ug)
Lanes 4 and 7:
Rat brain (50ug)
Predicted band size: 166 kDa
false
- WB
Unknown
Western blot - Anti-NMDAR2B antibody [NR2B] (AB28373)
All lanes:
Western blot - Anti-NMDAR2B antibody [NR2B] (ab28373) at 2 µg/mL
All lanes:
mouse brain tissue
Predicted band size: 166 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The NMDAR2B subunit contributes to the regulation of synaptic strength and is essential for processes involved in learning and memory. As part of the NMDA receptor complex it mediates excitatory neurotransmission and is involved in synaptic plasticity processes such as long-term potentiation (LTP). These functions are significant for cognitive function and neural development. The receptor's role in signal transduction is aided by the unique properties conferred by the NMDAR2B subunit such as its high affinity for glycine and slower deactivation kinetics.
Pathways
NMDAR2B is involved in the glutamatergic signaling pathway which is important for neural communication. It also participates in the calcium signaling pathway affecting cellular responses to external stimuli. The protein interacts with CaMKII and PSD-95 which are proteins that influence synaptic strength and architecture through these pathways. Its involvement links it to a variety of signaling events important for brain function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (40)
Recent publications for all applications. Explore the full list and refine your search
The Journal of international medical research 52:3000605241235589 PubMed38546233
2024
Applications
Unspecified application
Species
Unspecified reactive species
CNS neuroscience & therapeutics 30:e14694 PubMed38532579
2024
Applications
Unspecified application
Species
Unspecified reactive species
Genes, brain, and behavior 22:e12863 PubMed37575018
2023
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 18:e0284626 PubMed37216352
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 16:981190 PubMed36187288
2022
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 17:e0273803 PubMed36048782
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC complementary medicine and therapies 22:147 PubMed35643519
2022
Applications
Unspecified application
Species
Unspecified reactive species
The international journal of neuropsychopharmacology 25:498-511 PubMed35152284
2022
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2021:2146001 PubMed34777532
2021
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's & dementia : the journal of the Alzheimer's Association 18:318-338 PubMed34057756
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com